Tranche Update on Balchem Corporation's Equity Buyback Plan announced on August 6, 1999.
April 30, 2021 at 03:14 pm EDT
Share
From January 1, 2021 to March 31, 2021, the company has repurchased 13,475 shares, representing 0.04% for $1.6 million. With this, the company has completed the repurchase of 2,581,871 shares, representing 10% for $57.32 million under the buyback announced on August 6, 1999.
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. The Company's segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. Through Specialty Products, it re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
BALCHEM CORPORATION 
